Vivici Secures US Production for Precision-Fermented Dairy Protein via Liberation Labs Deal

Dutch precision fermentation company, Vivici, has secured a manufacturing partnership with US-based Liberation Labs to produce beta-lactoglobulin (BLG) protein ingredient, Vivitein. The product will be manufactured at Liberation Labs’ new facility in Richmond, Indiana, with commercial-scale output starting in 2026. The partnership will allow Vivici to expand its manufacturing capabilities beyond Europe and meet customer demand in the United States.

Vivitein BLG is a dairy-identical protein produced through precision fermentation for use in high-protein applications like clear beverages, protein powders, and snack bars. The ingredient, similar to whey protein, can replace traditional dairy components in product formulations. Liberation Labs CEO Mark Warner sees Vivici as a perfect fit for their facility, aligning with their model of scaled fermentation infrastructure for novel ingredients that offer cost-effective and sustainable manufacturing solutions.